Gimv

Gimv is a European investment company founded in 1980, based in Antwerp, Belgium, with a strong focus on private equity and venture capital. With over three decades of experience, Gimv manages approximately 1.8 billion EUR in investments across 85 portfolio companies, which collectively generate over 6 billion EUR in turnover and employ more than 28,000 professionals. The firm targets medium-sized and large growth companies with enterprise values ranging from 75 million to 750 million EUR, primarily within the Benelux, France, and Germany. Gimv's investment strategy encompasses four main platforms: Consumer 2020, Health & Care, Smart Industries, and Sustainable Cities, allowing them to identify and support innovative companies with high-growth potential. The firm also manages the Gimv Czech Ventures Fund, focusing on investments in the software sector in the Czech Republic. Through its dedicated teams and extensive international network, Gimv aims to facilitate the transformation of its portfolio companies into market leaders.

Pieter Alliet

Senior Associate

Roxane Ameline

Associate

Jelle Assink

Principal

Guillaume Bardy

Partner

Ronald Bartel

Partner

Ferdinand Becker

Senior Associate

Alex Behaeghe

Partner

Laurens Boriale

Senior Associate

Koen Bouckaert

Managing Partner - Head Consumer

Alexandre Brestin

Associate, Smart Industries

Kristof Vande Capelle

CFO

Anne Caron

Partner

Rishabh Chawla

Senior Associate

Lisa Collet

Principal

Koen Dejonckheere

CEO

Robin Dheedene

Associate

Bart Diels

Managing Partner, Head of Healthcare, Healthcare, Belgium

Martin van Dieten

Analyst

Pierre Egot

Principal

Patrick Franken

Partner, Consumer

Thomas Goudriaan

Senior Associate

Philipp Von Hammerstein

Partner

Lisa Hengerer

Principal, Smart Industries

Mathieu Himpe

Principal

von den Hoff, Maximilian

Principal

Dirk Jonkman

Principal

Andreas Jurgeit Ph.D

Partner, Life Sciences

Hidde Van Kerckhoven

Principal

Kevin Klein

Senior Principal, Healthcare

Christoph Kocher

Senior Associate

Elderd Land

Partner

Marie-Justine Lecomte

Associate, Health and Care

Gautier Lefebvre

Principal

Erik Mampaey

Managing Partner

Maja Markovic

Principal

Stéphanie Massart

Principal

Nick Medaer

Partner

Stephane Mircich

Principal

Ruben Monballieu

Partner

David De Peuter

Senior Principal, Consumer

Hadrien Pigot

Senior Associate

Moritz Plesser

Associate

Rombout Poos

Finance Director and Business Analyst

Christophe Van Quickenborne

Partner

Morgane Renault

Principal, Consumer

François-Xavier Rico

Principal

Clemence Robles

Principal

Tom Roth

Associate, Connected Consumer

Patrick Schaich

Principal

Sami Schyvinck

Senior Associate

Catharina Soenen

Principal, Sustainable Cities

Elsa Spangenberg

Associate, Healthcare

Lars Timmer

Senior Principal, Healthcare

Muriel Uytterhaegen

Principal, Smart Industries

Bram Vanparys

Partner

Eric de La Vigne

Principal

Michaël Vlemmix

Partner, Life Sciences

Tom Voorde

Managing Partner - Head of Smart Industries and member of Investment Committee

Cos Vrins

Senior Associate

Friedrich Wallwitz

Principal

Kalle Wanner

Principal, Sustainable Cities

Doriane Wattinne

Associate

Niklas Windmann

Senior Associate

Boris Wirtz

Principal

Fabian Wolfgarten

Associate

Nicolas de Saint Laon

Partner - Head Gimv France, Sustainable Cities, France

Past deals in Belgium

Precirix

Series B in 2022
Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Televic

Acquisition in 2020
Televic N.V. is a Belgium-based company that specializes in developing, manufacturing, and installing advanced communication products and solutions tailored for various sectors, including healthcare, education, railways, and conferencing. Founded in 1946, Televic offers a wide range of integrated audio-visual systems for settings such as conference rooms, auditoria, and control rooms, as well as on-board communication systems and passenger information solutions for the transportation industry. The company also provides digital networks for nurse call systems, intercoms, and patient entertainment. In education, Televic delivers innovative solutions, including digital and wireless language labs, virtualized learning environments, and classroom management software. With a commitment to high-tech quality, Televic aims to expand its global presence while maintaining a leading position in its specialized markets.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Biotalys

Series C in 2019
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Alro Group

Acquisition in 2019
The Alro Group is a leading provider of coating services for the automotive industry, headquartered in Dilsen-Stokkem, Belgium. With a significant presence in Western and Central Europe, the company has evolved from a small operation into a reputable group specializing in various coating techniques. Alro Group offers a range of services including wet coating, electrocoating, powder coating, and assembly, allowing clients to obtain tailored metal and plastic products that meet their specific needs.

Precirix

Series A in 2018
Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Impact

Acquisition in 2018
Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

Cegeka

Venture Round in 2017
Cegeka is a European IT services provider specializing in ICT solutions, consultancy, and digital transformation services. Established in 1986, the company has evolved from its origins in Belgium into a significant player with a presence in ten European countries. Cegeka offers a comprehensive portfolio that includes cloud computing, cybersecurity, software development, application management, data intelligence, and IT outsourcing. With over 5,000 employees, the company operates its own data centers in Belgium and the Netherlands, providing customers with reliable IT infrastructure and support. Cegeka has achieved notable growth through strategic acquisitions and aims to help businesses navigate the complexities of the digital landscape while enhancing their operational efficiency and competitive advantage.

Biotalys

Series B in 2017
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Itineris

Venture Round in 2017
Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.
Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

Contraload

Private Equity Round in 2016
Contraload is a fast growing Pan European company in pooling and rental services for plastic pallets and bins. For more than 10 years CLD has been focusing on plastic load carriers and has close to 1 million assets in its pool, all constantly on the move within the whole of Europe. CLD has a broad range of plastic pallets and IBCs for many different supply chains. Focus lies on the more complex food and FMCG supply chains with demanding and challenging global customers like Unilever, Nestle, Intersnack and many others. CLD helps its customers to meet the high quality and hygienic requirements, avoid foreign body contamination and to connect to suppliers or customers in a cost effective way. “CLD helps you carry the load”, so you can focus on your core business.

Itho Daalderop

Acquisition in 2016
Itho Daalderop Group B.V. is a Netherlands-based company specializing in the development, manufacturing, and marketing of HVAC products for the residential sector. Founded in 1880 and operating as a subsidiary of Klimaatgarant B.V., the company offers a wide range of products including central heating systems, heat pumps, solar boilers, kitchen boilers, and ventilation systems. Itho Daalderop is dedicated to providing innovative solutions that ensure a healthy, comfortable, energy-efficient, and affordable indoor climate. The company also serves as an advisory partner to governments, corporations, and construction firms, supporting them in new construction, renovation, and replacement projects. With its headquarters in Schiedam and additional locations in Etten-Leur, Tiel, the United Kingdom, and Sint-Niklaas, Belgium, Itho Daalderop continues to expand its reach both domestically and internationally.

CoScale

Venture Round in 2015
CoScale NV provides software solutions for IT operations analytics. It offers integrated platform to monitor full stack of containerized applications. It also provides COSCALE Application Performance Analyzer software that gathers and correlates data from Web applications and the underlying infrastructure to automatically identify and isolate disruptions, inefficiencies, and failures in Web applications; and enable organizations to optimize its infrastructure. The company offers its product as a subscription and licensing model for organizations operating in areas, such as e-commerce, online banking, online customer service, etc. CoScale NV was founded in 2013 and is based in Ghent, Belgium.

Itineris

Venture Round in 2015
Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.

EcoChem International

Acquisition in 2014
EcoChem International is a manufacturer and distributor of eco-friendly flame retardant additives, primarily serving the building and construction, transportation, and electronic sectors. The company's products are incorporated into materials such as wood, insulation, textiles, and plastics to inhibit, suppress, or delay flame and smoke production in the event of a fire. Headquartered in Olen, Belgium, EcoChem operates production facilities in Willebroek, Belgium, and Offenbach, Germany, and caters to clients across 25 countries. By offering economically viable solutions that prioritize environmental protection, EcoChem aims to meet the growing demand for sustainable fire safety products.

Ablynx

Grant in 2014
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

NovoPolymers

Private Equity Round in 2013
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Complix

Series B in 2013
Complix NV is a biopharmaceutical company based in Diepenbeek, Belgium, with research facilities in Zwijnaarde, Belgium, and an office in Esch-sur-Alzette, Luxembourg. Founded in 2008, the company specializes in the discovery and development of Alphabodies, a novel class of protein therapeutics designed to target difficult disease sites, particularly in oncology and autoimmune diseases. These Alphabodies demonstrate high affinity for a variety of disease targets and possess unique stability and versatility, enabling non-injectable delivery methods. Complix aims to address challenging intracellular targets, thereby offering patients alternatives to traditional antibodies and small molecules, with the intent of improving treatment outcomes for complex conditions such as cancer, autoimmune disorders, and viral diseases.

Luciad

Acquisition in 2013
Luciad provides high performance software tools for rapid application development of advanced systems. Our applications simplify the lives of developers and end users with advanced visual analytics that allow them to unlock the potential of real time location intelligence and create the foundations for next generation geospatial systems. From safeguarding critical assets to creating the digital infrastructure for smart cities, we help users implement intuitive command and control systems. Our customers depend on Luciad for high performance visualization that allows them to implement scalable solutions.

Lampiris

Venture Round in 2013
Lampiris N.V., founded in 2003 and based in Liège, Belgium, is an independent supplier of electricity and gas, serving both private individuals and businesses. The company has been active in the Belgian energy market since 2005 and has established itself as the third-largest supplier in the residential sector, with over a million accounts. In addition to energy supply, Lampiris offers various energy services, including insulation, furnace maintenance, and heating solutions using wood and pellets, as well as smart thermostats. As of September 2016, Lampiris operates as a subsidiary of Elf Aquitaine S.A.

Multiplicom

Venture Round in 2013
Multiplicom N.V., founded in 2010 and based in Niel, Belgium, specializes in developing molecular diagnostic test kits that facilitate the collection of genetic information for personalized treatment. The company offers a range of diagnostic assays across three main segments: human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiovascular disorders, such as various BRCA and HNPCC assays. In oncology, Multiplicom provides kits for molecular tumor pathology and cancer genetics, including several BRCA and somatic tests. For prenatal diagnostics, the company offers the Clarigo product to detect chromosome abnormalities. Multiplicom also operates an informatics facility in Gent, Belgium, and has an additional office in Lyon, France. As of January 2017, Multiplicom N.V. is a subsidiary of Agilent Technologies, Inc.

Biotalys

Venture Round in 2013
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

NovoPolymers

Venture Round in 2012
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

GreenWatt

Venture Round in 2012
GreenWatt is a CleanTech company specializing in the development of anaerobic digestor plants that convert organic waste into renewable energy. The company provides comprehensive engineering services, including feasibility studies, construction, and the startup of turn-key small-scale biogas plants. Utilizing innovative and patented technologies, GreenWatt addresses key challenges associated with anaerobic digestion. Its installations are designed to integrate locally within the agro-food and beverage industries, offering a cost-effective and efficient solution for waste management and energy production.

Pronota

Series C in 2012
Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

VCST Industrial Products

Acquisition in 2011
VCST is a world-class automotive supplier of precision-machined powertrain and brake components for Automotive OEM’s and Tier 1 suppliers. The company realized a turnover of 169 million euro in 2015 and employs 1250 full time employees. VCST has production facilities in Belgium, China, Germany, Mexico and Romania, with its headquarters located in Belgium.

Trustteam

Private Equity Round in 2011
Trustteam NV is a provider of comprehensive information technology solutions for businesses, established in 2002 and headquartered in Kortrijk, Belgium, with additional locations in Heusden-Zolder and Paris. The company specializes in a range of services including cloud solutions, security, telephony, software, hardware, and IT consulting. Trustteam focuses on delivering outsourced IT management services that address various technology-related challenges faced by enterprises. By offering a complete suite of services, including security awareness training and digitization, Trustteam helps clients from diverse industries streamline their operations and concentrate on their core business activities, effectively alleviating their IT concerns.

XL Video

Venture Round in 2011
XL Video, based in Ostend, Belgium, specializes in the rental of video display systems for a wide range of events, including concerts, theater shows, corporate gatherings, and television productions. Founded in 1996 by CEO René de Keijzer, the company has established itself as a global leader in video technology rental. XL Video's inventory includes high-end video equipment such as LED displays, projection systems, plasma and LCD screens, as well as HD camera systems. Additionally, the company operates large trucks equipped with built-in video screens to facilitate event production. XL Video also designs and sells its own LED systems under the brand name Pixled, further enhancing its offerings in the video technology sector.

Multiplicom

Venture Round in 2011
Multiplicom N.V., founded in 2010 and based in Niel, Belgium, specializes in developing molecular diagnostic test kits that facilitate the collection of genetic information for personalized treatment. The company offers a range of diagnostic assays across three main segments: human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiovascular disorders, such as various BRCA and HNPCC assays. In oncology, Multiplicom provides kits for molecular tumor pathology and cancer genetics, including several BRCA and somatic tests. For prenatal diagnostics, the company offers the Clarigo product to detect chromosome abnormalities. Multiplicom also operates an informatics facility in Gent, Belgium, and has an additional office in Lyon, France. As of January 2017, Multiplicom N.V. is a subsidiary of Agilent Technologies, Inc.

NovoPolymers

Series B in 2011
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

NomaDesk

Series B in 2010
Nomadesk NV is a European SaaS company established in 2004, specializing in cloud-based enterprise file sharing and synchronization technology solutions. Headquartered in Sint-Martens-Latem, Belgium, the company provides a range of services including the Nomadesk Public Cloud, which enables users to manage their electronic documents securely online and offline, and NMD | HyperDrive, which offers enhanced security through a virtualized enterprise-grade infrastructure. Nomadesk also provides an On-Premises solution, allowing partners to host cloud-based file sharing services in their own data centers. The company primarily targets distributors, resellers, service providers, and system integrators, who can offer Nomadesk's solutions under their own brand. With data centers located in Frankfurt, Amsterdam, and Asheville, North Carolina, Nomadesk serves both European and American customers. It operates as a subsidiary of UnifiedPost, an international provider of integrated business process optimization solutions.

Private Outlet

Venture Round in 2010
Private Outlet SAS is an online retail company based in Saint-Denis, France, specializing in apparel and lifestyle products for men, women, and children across several European countries, including France, Germany, and the United Kingdom. Established in 2006, the company operates as a shopping club that organizes exclusive short sale events featuring well-known brands, offering discounts of up to 70% on a wide range of products. Its offerings include ready-to-wear clothing, footwear, accessories, beauty products, and home goods, all within a secure shopping environment. Private Outlet caters to fashion enthusiasts looking for new trends and styles, positioning itself as a unique platform for brand engagement and consumer savings.

GreenPeak Technologies

Series B in 2009
GreenPeak Technologies BV, a fabless semiconductor/system company, develops ultra-low power wireless data communication controller chips for smart home applications and consumer electronics. It provides communication controller semiconductor products and software technologies for smart home data communications; a range of IEEE 802.15.4 and ZigBee silicon solutions; and Senior Lifestyle sensor and cloud based intelligent system technology to enable children and their elderly parents to privately and securely share lifestyle information. The company also offers integration, support, and training services. It markets and sells its products to OEMs and ODMs in the United States, Europe, Asia, and Latin-America. GreenPeak Technologies BV has a strategic partnership with Sensara. GreenPeak Technologies BV was formerly known as Xanadu Wireless BV and changed its name to GreenPeak Technologies BV in 2007. The company was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, China, France, the United States, Japan, and Korea. As of April 29, 2016, GreenPeak Technologies BV operates as a subsidiary of Qorvo, Inc.

Pronota

Series B in 2009
Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

NovoPolymers

Series A in 2009
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Luma International

Series A in 2009
Luma International, founded in 2009 by a diverse group of innovators and entrepreneurs, specializes in providing an on-demand marketing platform tailored for field and channel sales. The company supports medium and large enterprises, including notable clients such as Toyota, Mercedes-Benz, Coca-Cola, and Bacardi, by enabling them to create personalized marketing materials efficiently, thereby enhancing sales and reducing costs. Luma's platform not only improves marketing flexibility and campaign effectiveness but also ensures brand consistency across different sectors. Additionally, Luma's capabilities are closely aligned with Marketing Resource Management, Enterprise 2.0, and Ecommerce 2.0. The company has established offices in Antwerp, Rotterdam, Paris, and Redwood Shores, demonstrating its commitment to innovation in digital and personalized marketing.

Vandemoortele

Private Equity Round in 2009
Vandemoortele is a family-owned Belgian food group headquartered in Ghent, specializing in the production of high-quality food products. The company operates primarily in two segments: frozen bakery products and margarines and fats. Its product range includes frozen bakery items, bread, pastries, donuts, and culinary oils, as well as margarine and soy foods. Vandemoortele is committed to providing healthy and safe food options to its customers, emphasizing quality and European standards in its manufacturing processes.

ActoGeniX

Private Equity Round in 2009
ActoGeniX is a biopharmaceutical company based in Zwijnaarde, Belgium, founded in 2006 by Bernard Coulie and Mark Vaeck. The company specializes in the development and commercialization of innovative biological drugs, utilizing a proprietary technology platform that leverages living non-pathogenic microorganisms for oral delivery of biopharmaceuticals. ActoGeniX aims to address unmet medical needs in gastrointestinal, immunological, and metabolic diseases, contributing to advancements in therapeutic options within these fields.

Clear2Pay

Venture Round in 2008
Clear2Pay is a payments technology company that specializes in providing innovative solutions for secure and efficient payment processing. Its key offering, the Open Payment Framework (OPF), allows financial institutions to enhance their internal payment processing while delivering improved services to clients, characterized by speed and detailed payment information. The OPF employs a centralized payments engine supported by a library of reusable business services, enabling banks to integrate new service models with their existing infrastructures. This approach helps institutions modernize their payment systems while safeguarding previous investments. Additionally, Clear2Pay offers a Software Development Kit and a Bank Payment Hub, which facilitate customer interaction, order management, and payment execution, along with services for dispute and exception processing.

Viabuild

Private Equity Round in 2008
Viabuild Group N.V. provides road, civil, and drainage construction services. Viabuild Group N.V. was formerly known as Verhaeren Kembo Groep NV and changed its name to Viabuild Group N.V. in October, 2012. The company is based in Mechelen, Belgium. Viabuild Group N.V. operates as a subsidiary of NV Verhaeren & Co.

Diatos

Series D in 2007
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).

NomaDesk

Series A in 2007
Nomadesk NV is a European SaaS company established in 2004, specializing in cloud-based enterprise file sharing and synchronization technology solutions. Headquartered in Sint-Martens-Latem, Belgium, the company provides a range of services including the Nomadesk Public Cloud, which enables users to manage their electronic documents securely online and offline, and NMD | HyperDrive, which offers enhanced security through a virtualized enterprise-grade infrastructure. Nomadesk also provides an On-Premises solution, allowing partners to host cloud-based file sharing services in their own data centers. The company primarily targets distributors, resellers, service providers, and system integrators, who can offer Nomadesk's solutions under their own brand. With data centers located in Frankfurt, Amsterdam, and Asheville, North Carolina, Nomadesk serves both European and American customers. It operates as a subsidiary of UnifiedPost, an international provider of integrated business process optimization solutions.

ActoGeniX

Venture Round in 2007
ActoGeniX is a biopharmaceutical company based in Zwijnaarde, Belgium, founded in 2006 by Bernard Coulie and Mark Vaeck. The company specializes in the development and commercialization of innovative biological drugs, utilizing a proprietary technology platform that leverages living non-pathogenic microorganisms for oral delivery of biopharmaceuticals. ActoGeniX aims to address unmet medical needs in gastrointestinal, immunological, and metabolic diseases, contributing to advancements in therapeutic options within these fields.

Movetis

Series A in 2007
Movetis NV is a pharmaceutical company dedicated to the discovery, development, and commercialization of drugs targeting gastrointestinal (GI) disorders. The company addresses a range of conditions, including severe chronic constipation, ascites, and pediatric reflux, as well as severe GI motility disorders like refractory gastro-oesophageal reflux disease. Its lead product, Resolor, is specifically designed for the symptomatic treatment of chronic constipation in women, with ongoing research for its efficacy in males and children, as well as in cases of opioid-induced constipation and post-operative ileus. Movetis is also developing M0002, currently in Phase II trials for treating ascites, and M0003, which is set to enter Phase II development for symptomatic relief of heartburn and regurgitation in patients unresponsive to proton pump inhibitors. Additionally, the company has two prioritized compounds from its preclinical portfolio and maintains partnerships with universities in Ghent, Leuven, and Rotterdam. Founded in 2006, Movetis is based in Turnhout, Belgium.

Accent Jobs

Private Equity Round in 2006
Accent Jobs for People NV is a recruitment agency based in Roeselare, Belgium, specializing in temporary employee recruitment and leasing services. Founded in 1995, the company has established a significant presence in the Belgian temporary labor market within a decade of its inception. Accent Jobs provides job opportunities across various sectors, including construction, engineering, production, sales and marketing, logistics and distribution, and tourism. In addition to its core recruitment services, the company also offers training, consulting, contract staffing, outsourcing, and outplacement services, catering to a diverse range of career-related needs.

Ablynx

Series C in 2006
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

Pronota

Series A in 2006
Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in providing innovative solutions for secure and efficient payment processing. Its key offering, the Open Payment Framework (OPF), allows financial institutions to enhance their internal payment processing while delivering improved services to clients, characterized by speed and detailed payment information. The OPF employs a centralized payments engine supported by a library of reusable business services, enabling banks to integrate new service models with their existing infrastructures. This approach helps institutions modernize their payment systems while safeguarding previous investments. Additionally, Clear2Pay offers a Software Development Kit and a Bank Payment Hub, which facilitate customer interaction, order management, and payment execution, along with services for dispute and exception processing.

GreenPeak Technologies

Venture Round in 2006
GreenPeak Technologies BV, a fabless semiconductor/system company, develops ultra-low power wireless data communication controller chips for smart home applications and consumer electronics. It provides communication controller semiconductor products and software technologies for smart home data communications; a range of IEEE 802.15.4 and ZigBee silicon solutions; and Senior Lifestyle sensor and cloud based intelligent system technology to enable children and their elderly parents to privately and securely share lifestyle information. The company also offers integration, support, and training services. It markets and sells its products to OEMs and ODMs in the United States, Europe, Asia, and Latin-America. GreenPeak Technologies BV has a strategic partnership with Sensara. GreenPeak Technologies BV was formerly known as Xanadu Wireless BV and changed its name to GreenPeak Technologies BV in 2007. The company was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, China, France, the United States, Japan, and Korea. As of April 29, 2016, GreenPeak Technologies BV operates as a subsidiary of Qorvo, Inc.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Ablynx

Series B in 2004
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

Ablynx

Series A in 2002
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

ORMvision

Series B in 2001
Ormvision is a provider of relationship management systems to the telecom industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.